Search research articles
Contact Us
Filters
Showing results (351-360 of 574) with videos related to
Page
of 58
Sort By:
Rheumatology (Oxford, England)
|
May 16, 2024
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies
Laure Gossec, Ana-Maria Orbai, Maarten de Wit, et al.
Clinical Therapeutics
|
August 4, 2023
Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review
Louise H Hailey, Raj Amarnani, Chris Bundy, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
Best-practice Indicators in Psoriatic Disease Care
Philip S Helliwell, Guillaume Favier, Dafna D Gladman, et al.
The British Journal of Dermatology
|
March 8, 2022
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis
Kristian Reich, Xenophon Baraliakos, Laura C Coates, et al.
Trials
|
January 10, 2023
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
Christopher T Ritchlin, Laura C Coates, Philip J Mease, et al.
Nature Reviews. Disease Primers
|
August 13, 2021
Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Plant Physiology
|
July 10, 2023
Nt-acetylation-independent turnover of SQUALENE EPOXIDASE 1 by Arabidopsis DOA10-like E3 ligases
Ross D Etherington, Mark Bailey, Jean-Baptiste Boyer, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
January 7, 2016
A Novel Specialty-Specific, Collaborative Faculty Development Opportunity in Education Research: Program Evaluation at Five Years
Jeffrey N Love, Lalena M Yarris, Sally A Santen, et al.
Arthritis Care & Research
|
February 7, 2018
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study
Laura C Coates, Philip J Mease, Laure Gossec, et al.
Rheumatology (Oxford, England)
|
November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK
Charlotte E Gollins, Annie Russell, Theresa Smith, et al.
Page
of 58
Search research articles
Search
Showing results (351-360 of 574) with videos related to
Sort By:
Page
of 58
Rheumatology (Oxford, England)
|
May 16, 2024
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies
Laure Gossec, Ana-Maria Orbai, Maarten de Wit, et al.
Clinical Therapeutics
|
August 4, 2023
Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review
Louise H Hailey, Raj Amarnani, Chris Bundy, et al.
The Journal of Rheumatology. Supplement
|
June 3, 2019
Best-practice Indicators in Psoriatic Disease Care
Philip S Helliwell, Guillaume Favier, Dafna D Gladman, et al.
The British Journal of Dermatology
|
March 8, 2022
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis
Kristian Reich, Xenophon Baraliakos, Laura C Coates, et al.
Trials
|
January 10, 2023
The effect of guselkumab on inhibiting radiographic progression in patients with active psoriatic arthritis: study protocol for APEX, a Phase 3b, multicenter, randomized, double-blind, placebo-controlled trial
Christopher T Ritchlin, Laura C Coates, Philip J Mease, et al.
Nature Reviews. Disease Primers
|
August 13, 2021
Psoriatic arthritis
Oliver FitzGerald, Alexis Ogdie, Vinod Chandran, et al.
Plant Physiology
|
July 10, 2023
Nt-acetylation-independent turnover of SQUALENE EPOXIDASE 1 by Arabidopsis DOA10-like E3 ligases
Ross D Etherington, Mark Bailey, Jean-Baptiste Boyer, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
January 7, 2016
A Novel Specialty-Specific, Collaborative Faculty Development Opportunity in Education Research: Program Evaluation at Five Years
Jeffrey N Love, Lalena M Yarris, Sally A Santen, et al.
Arthritis Care & Research
|
February 7, 2018
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study
Laura C Coates, Philip J Mease, Laure Gossec, et al.
Rheumatology (Oxford, England)
|
November 8, 2025
A retrospective observational study of effectiveness of sequential biologic and targeted synthetic DMARDs in psoriatic arthritis in the UK
Charlotte E Gollins, Annie Russell, Theresa Smith, et al.
Page
of 58